What is Rectal Cancer?
Rectal cancer, a type of colorectal cancer, arises from malignant cells in the rectum, the last several inches of the large intestine.
Rectal cancer is not as uncommon as one might think.
According to the American Cancer Society’s estimates for 2023, there are anticipated to be 46,050 new cases of rectal cancer in the United States.1 and approximately 5% of people will develop rectal cancer at some point in their lives.2.
Worldwide, the International Agency for Research on Cancer estimates an increase of 79.5% in new cases between 2022 and 2050.3
Brachytherapy (internal radiation therapy) is a type of radiation therapy used to treat certain rectal cancers.
For this treatment, the applicator, specifically tailored for the rectum, facilitates the passage of the radioactive material, enabling radiation delivery. This allows the radiation to reach the rectum without passing through the skin and other tissues of the belly (abdomen), so it’s less likely to damage nearby anatomical surroundings.
This treatment approach is highly effective in treating a specific subset of rectal cancer types and patients. It has shown a high cure rate, especially when combined with other treatment modalities. It is also associated with fewer side effects than traditional radiation therapy or surgery.
Patients need to discuss their rectal cancer treatment options with their healthcare providers. Brachytherapy may not be the best option for every patient, and other treatment options may be more appropriate depending on the stage and severity of the cancer. When deciding on a treatment plan, the doctor will consider and discuss several factors with the patient, such as the patient’s age, overall health, and personal preferences.